drugset / Trial / NCT01130181

VITdAL@ICU - Correction of Vitamin D Deficiency in Critically Ill Patients

NCT01130181 ↗

Phase 3 Completed 480 enrolled Harald Dobnig, MD
RandomizedParallel-groupTriple-blindTreatment

Summary

Study hypothesis: High-dose vitamin D leads to a shorter hospital stay in critically ill patients Vitamin D deficient patients will be randomized to receive either 540,000 IU cholecalciferol or placebo.

Timeline

Start
2010-05
Primary completion
2012-09
Completion
2012-09

Outcome

Missed primary endpoint

paper The median (IQR) length of hospital stay was not significantly different between groups (20.1 days [IQR, 11.1-33.3] for vitamin D3 vs 19.3 days [IQR, 11.1-34.9] for placebo; P = .98). PMID 25268295 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 90000 iu Oral

Indications